We’re recruiting a PhD student at King’s College London @KingsIoPPN to use AI and big data (@uk_biobank) to uncover sex-specific molecular subtypes of Alzheimer’s and translate them into drug repurposing opportunities. www.linkedin.com/posts/ahmad-...

PhD Opportunity 🔉🔊 Interested in mixing epigenetics + AI to transform clinical trials? Join us (with David Watson& Sarah Marzi) to explore DNA methylation as a tool to personalise trials. 🧬🖥️ Think big data & machine learning applied where it really matters kcl-mrcdtp.com/project/harn...

🚨 Join us for the next DEMON Network Drug Discovery & Clinical Trials seminar! 🗓 today Thu 25 Sept, 3:30pm 🇬🇧 🎤 Prof Karyn Frick (Univ. of Wisconsin–Milwaukee) 🧠 Estrogens & memory: Translating basic research into therapies for menopause & Alzheimer’s disease

Excited to host a Nvidia workshop at @kingscollegelondon.bsky.social Join Dr Ben Busby to explore how accelerated platforms are transforming genomics, imaging & biomedical devices. 📅 25 July 🕒 11am 🇬🇧 📍 SGDP Centre, Denmark Hill 🔗 lnkd.in/eJggPCj5

A toddler shows no signs of Spinal Muscular Atrophy after being treated in the womb— a first for the motor neuron disease, which causes muscle weakness and loss of movement. A breakthrough showing the power of early diagnosis and treatment! #SMA www.nejm.org/doi/full/10....

Genetic testing for #ALS #MND should go beyond identifying a single mutation. Even if a known genetic cause is found. A comprehensive analysis provides a clearer understanding of the condition and can help guide care &research efforts. Happy to help in this fantastic project.

Join us at The Deep Dementia Phenotyping Network for a special event with Prof Azzouz, Founder & Director of the Gene Therapy Innovation & Manufacturing Centre at university of Sheffield 🗓️ Jan 31 | 3pm 🇬🇧 Topic: "Sheffield Gene Therapy Ecosystem for Translational Research & Clinical Trials"

Funded PhD at King's College London with @ahmadalkhleifat.bsky.social & @sj-marzi.bsky.social - #ALS in a Global Context: Integrating #Genomics and #Epigenomics Data from Diverse Populations. Closing date: 30th January www.dementiaresearcher.nihr.ac.uk/job/phd-als-...

Funded PhD at King's College London with @ahmadalkhleifat.bsky.social & @sj-marzi.bsky.social - Integration of epigenetic profile in #MND clinical trials design. #ALS @ukmndri.bsky.social www.dementiaresearcher.nihr.ac.uk/job/phd-inte...

Funded PhD with @ahmadalkhleifat.bsky.social at King's College London exploring PrognostiOmics: Multiomics Scores for Predicting Age of Onset in ALS. @ukmndri.bsky.social - Closing date: 30th January www.dementiaresearcher.nihr.ac.uk/job/phd-mult...

Funded PhD with @ahmadalkhleifat.bsky.social at King's College London 'Optimizing Clinical Trials in Motor Neuron Disease: Harnessing Immune Biomarkers and Machine Learning for Predicting Disease Progression. Closing date: 30th January www.dementiaresearcher.nihr.ac.uk/job/phd-immu...

🎧 Insights from the #ALSMNDSymposium ! Hear from Dr Alys Griffiths, Dr Megan Fowler, Professor Eneida Mioshi, and @ahmadalkhleifat.bsky.social as they unpack the latest research. #Podcast pod.fo/e/2903ef

Join us on 29th Nov, 1 PM (🇬🇧) for the next Deep Dementia Phenotyping (DEMON) Network Drug Discovery and Trials Optimisation meeting! Dr Oscar Wilkins will present: "Using disease mechanisms to our advantage: new technologies for ALS gene therapies." Explore innovations in #ALS #MND gene therapy.

Great to have Dr David Watson and Jordan Penn at King’s MND centre today, sharing insights on MR methodologies and #AI applications in #genomics! #ALS #MND